The 2026 Regulatory Landscape: FDA ImportShield
On January 21, 2026, the FDA launched the ImportShield Program, a centralized modernization effort to protect U.S. ports.
Centralized Oversight: The program unified five regional teams into a single operation to ensure consistent screening across all U.S. points of entry.
Real-Time Alerts: If a counterfeit version of a drug (like the 2025/2026 Ozempic fakes) is detected in one port, a "Nationwide Alert" is instantly triggered for all other entry points.
DSCSA Compliance: 2026 marks a full-implementation year for the Drug Supply Chain Security Act (DSCSA), requiring 100% electronic, unit-level traceability for all pharmaceuticals.
4 visualizações